Out-of-pocket medical expenses in severe CHD

Justin J Elhoff1, Kimberly E McHugh2, Jason R Buckley2

  • 11Texas Children's Hospital,Department of Pediatrics,Baylor College of Medicine,Houston,TX,USA.

Insights

Families with commercially insured children needing surgery for severe congenital heart defects (CHD) faced average out-of-pocket costs of nearly $3000 in the first year. This study quantifies financial burdens for these families.

Area of Science:

  • Pediatric Cardiology
  • Health Economics
  • Medical Finance

Background:

  • Families of children with congenital heart defects (CHD) experience significant financial stress due to unpredictable medical costs.
  • Understanding the financial burden is crucial for supporting families and informing healthcare policy.

Purpose of the Study:

  • To assess the out-of-pocket healthcare expenses incurred by families of commercially insured infants undergoing surgery for severe CHD within the first 12 months of life.

Main Methods:

  • Utilized the MarketScan database (2010-2012) to identify infants with specific severe CHD diagnoses (transposition of the great arteries, tetralogy of Fallot, truncus arteriosus) requiring surgical repair.
  • Extracted family financial responsibilities, including co-payments, deductibles, and co-insurance, for the initial year post-diagnosis.

Main Results:

  • Identified 481 infants meeting the study criteria.
  • Average family out-of-pocket costs were $2928 for the first year, with no significant difference across the studied CHD types.
  • Costs ranged widely from $50 to $18,167, with initial hospitalization and outpatient care being the primary cost drivers.

Conclusions:

  • Commercially insured families with infants undergoing surgery for severe CHD incur average out-of-pocket healthcare costs of approximately $3000 in the first year.
  • While the average cost provides a benchmark, the considerable variation highlights the need for financial planning and support.
  • Findings can inform healthcare policy discussions and help alleviate financial uncertainty for affected families.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
810
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
261
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
220
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
367
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312